MMM vs BSX stock comparison
3M vs. Boston Scientific · data as of November 13, 2026
3M (MMM) has a market value of about $94.9B, Boston Scientific (BSX) about $64.3B. Over their latest twelve months 3M had revenue of $25.2B and Boston Scientific $21.1B.
On our five checks Boston Scientific scores higher: 3.0 out of 5 (average) against 1.4 (weak).
By area, the stronger company is Boston Scientific on value; Boston Scientific on future growth; Boston Scientific on track record; Boston Scientific on financial health; 3M on shareholder returns.
Boston Scientific is cheaper on earnings (P/E 18.8 vs. 27.4).
3M leads on 7 of the compared lines and Boston Scientific on 16.
Side by side
| MMM | BSX | |
|---|---|---|
| Size and price | ||
| Market cap | $94.9B | $64.3B |
| Share price | $183.66 | $44.34 |
| Score | ||
| Overall score (of 5) | 1.4 | 3.0 |
| Value | 0 | 3 |
| Future growth | 1 | 5 |
| Track record | 1 | 2 |
| Financial health | 1 | 4 |
| Shareholder returns | 4 | 1 |
| Valuation | ||
| P/E (TTM) | 27.4 | 18.8 |
| Forward P/E | 19.8 | 14.4 |
| Price / free cash flow | 35.5 | 19.3 |
| Price / sales | 3.8 | 3.1 |
| EV / EBITDA | 17.1 | 14.1 |
| PEG | — | — |
| DCF value vs. price | −52% | −58% |
| Business | ||
| Revenue | $25.2B | $21.1B |
| Net income | $3.5B | $3.5B |
| Free cash flow | $2.7B | $3.3B |
| Net margin | 14.0% | 16.6% |
| Gross margin (5-yr avg.) | 41.3% | 68.9% |
| ROIC (5-yr avg.) | 6.8% | 5.9% |
| Growth | ||
| Revenue growth (1 yr) | 1.5% | 19.9% |
| Revenue growth (5 yrs, per year) | -5.0% | 15.2% |
| EPS growth (5 yrs, per year) | -8.5% | — |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$10.8B | -$11.3B |
| Dividend yield | 1.70% | None |
| Shareholder yield | 5.1% | 0.0% |
| Analysts | ||
| Upside to average target | +5% | +12% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: MMM TTM to September 30, 2026, BSX TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, 3M or Boston Scientific?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Boston Scientific scores 3.0 out of 5 and 3M 1.4; the table shows where each one is stronger.
Is 3M cheaper than Boston Scientific?
On trailing earnings, Boston Scientific trades at a P/E of 18.8 and 3M at 27.4, so Boston Scientific is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, 3M or Boston Scientific?
Over five years Boston Scientific grew revenue about 15.2% a year and 3M about -5.0% a year.
Which pays a higher dividend?
3M yields 1.70% and Boston Scientific nothing (no dividend).
Full 3M analysis → Full Boston Scientific analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.